Inflammation in the pathogenesis of microvascular complications in diabetes (original) (raw)

Cardiovascular Research, 2004

Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

Nature Clinical Practice Endocrinology & Metabolism, 2008

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

jean-luc wautier

Journal of Clinical Investigation, 1996

View PDFchevron_right

Advanced glycation end products, their receptors and diabetic angiopathy

jean-luc wautier

Journal of the Peripheral Nervous System, 2002

View PDFchevron_right

Anti-receptor Advanced Glycation End Products Decreases Inflammatory Pathways in Retinopathy Diabetics: In vivo Study

riani erna

Open Access Macedonian Journal of Medical Sciences

View PDFchevron_right

Short- and long-term modulation of microvascular responses in streptozotocin-induced diabetic rats by glycosylated products

Zeinab Khalil

Journal of Diabetes and its Complications, 2010

View PDFchevron_right

Advanced glycation and endothelial functions: A link towards vascular complications in diabetes

Armando Rojas

Life Sciences, 2004

View PDFchevron_right

Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches

Rita Balistreri

Vascular Pharmacology, 2017

View PDFchevron_right

Role of Advanced Glycation End Products With Oxidative Stress in Resistance Artery Dysfunction in Type 2 Diabetic Mice

Bashir Rezk

Arteriosclerosis, Thrombosis, and Vascular Biology, 2008

View PDFchevron_right

The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach

franco folli

Current diabetes reviews, 2011

View PDFchevron_right

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions

jean-luc wautier

Arteriosclerosis, Thrombosis, and Vascular Biology, 1994

View PDFchevron_right

Diabetes, advanced glycation endproducts and vascular disease

jean-luc wautier

Vascular Medicine, 1998

View PDFchevron_right

Role of advanced glycation end products (AGEs) and its receptor (RAGE)-mediated diabetic vascular complications

Diwesh Chawla

Integrative Food, Nutrition and Metabolism, 2019

View PDFchevron_right

Endothelial Dysfunction in Type 2 Diabetes: Targeting Inflammation

Fernanda Carrilho

Endothelial Dysfunction - Old Concepts and New Challenges, 2018

View PDFchevron_right

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications

Assefa Teshome

Frontiers in Molecular Biosciences, 2022

View PDFchevron_right

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: a Mechanism for Amplification of Inflammatory Responses

P. Tanganelli

Circulation, 2002

View PDFchevron_right

Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications

Ciro Costagliola

Diabetes & Metabolism, 2019

View PDFchevron_right

Diabetic Vascular Disease: It's All the RAGE

Loredana Bucciarelli

Antioxidants & Redox Signaling, 2005

View PDFchevron_right

Send Orders for Reprints to reprints@benthamscience.ae A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure

yasir khan Mohd

BIOMAC 9424, 2018

View PDFchevron_right

Advanced glycation endproducts—role in pathology of diabetic complications

Nessar Ahmed

Diabetes Research and Clinical Practice, 2005

View PDFchevron_right

Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

Ann-marie Schmidt

Circulation Research, 2003

View PDFchevron_right

Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo

jean-luc wautier

Diabetes, 1999

View PDFchevron_right

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

Tina Soulis

Diabetologia, 1997

View PDFchevron_right

Diabetes‐associated macrovasculopathy: pathophysiology and pathogenesis

Sayeeda Rahman

Diabetes, Obesity and Metabolism, 2007

View PDFchevron_right

Correlation between Hyperglycemia Inflammation and Oxidative Stress in Type 2 Diabetic Nephropathy Subjects

fuleshwar mandal

International Journal of Pharmaceutical Biological Archive, 2012

View PDFchevron_right

Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes

Carlos Palmeira

Frontiers in Physiology

View PDFchevron_right

Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction

Judy Haan

Frontiers in bioscience (Scholar edition), 2011

View PDFchevron_right

Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes

Deyarina Gonzalez

Current Enzyme Inhibition, 2010

View PDFchevron_right

MODULATION OF NITRIC OXIDE PATHWAY BY MULTILIGANDS/RAGE AXIS: A CROSSING POINT IN THE ROAD TO MICROVASCULAR COMPLICATION IN DIABETES.

Current Enzyme Inhibition

View PDFchevron_right

Inflammation in the pathogenesis of microvascular complications in diabetes (original) (raw)

Related papers